Oral Solid Dosage Pharmaceutical Formulation Market is projected to achieve US$ 8,95,636.0 million by 2034 at a CAGR of 3.7%.

The partnership will see the application of AI-enabled screening to address bioavailability issues with Equillium’s ...

The Indian pharmaceutical sector is expected to maintain its growth, driven by a strategy focused on increasing market share ...

Today, the Center for Food Safety (CFS) filed a lawsuit under the Freedom of Information Act (FOIA) to compel the ...

Akhilesh Vats, Director of ACME Research Solutions, shares his perspective on the ongoing advancements in the field of formulation and development, a ...

NEWARK, DE / ACCESSWIRE / September 10, 2024 / The Inhalation Formulation Market is expected to grow steadily over the next ...

Join the audience for a live webinar on 6 November 2024 sponsored by TA Instruments – Waters in partnership with The ...

The US Food and Drug Administration (FDA) has approved atezolizumab and hyaluronidase-tqjs (Tecentriq Hybreza, Genentech, Inc ...

The ready-to-use formulation of bortezomib is now an FDA-approved option for patients with multiple myeloma and mantle cell ...

The product can be administered subcutaneously and intravenously, though each route of administration has a different final concentration.

Tharimmune, Inc. (NASDAQ:THAR) (”Tharimmune” or the “Company”), a clinical-stage biotechnology company developing a portfolio of therapeutic candidates in inflammation and immunology, announced today ...